Exploring Next-Generation Therapeutics: Morphic Mixtures and Specified Salts for the Treatment of Mental Disorders and CNS Modulation
ACS Medicinal Chemistry Letters August 22, 2023 DOI: 10.1021/acsmedchemlett.3c00358 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Commentary Peer reviewed |
|---|---|
| Key points | Argues that serotonin receptor subtypes 5-HT2A, 5-HT2C, 5-HT1A, and 5-HT1B are promising targets for treating central nervous system disorders, but that receptor modulation can cause side effects such as hallucinations and altered perception. Contends that developing 5-HT2A agonists with minimized mood changes and improved therapeutic benefit, along with morphic salt mixtures and specified salts, could offer innovative ways to modulate CNS activity and treat mental disorders. |
Abstract
This Patent Highlight delves into the potential of next-generation therapeutics for treating mental disorders and modulating the central nervous system (CNS). Among the serotonin receptor subtypes, 5-HT2A, 5-HT2C, 5-HT1A, and 5-HT1B have shown promise in CNS disorder treatment. Approved drugs targeting these receptors, such as antipsychotics and psychedelics, provide valuable insights into their therapeutic effects. However, modulation of these receptors can lead to side effects like hallucinations and altered perception. The development of 5-HT2A agonists with minimized mood changes and improved therapeutic benefits is crucial. Furthermore, exploring morphic salt mixtures and specified salts offers innovative approaches to effectively modulating CNS activity and treating mental disorders.
Citations in the library
Cites 4
- Toward Mapping Neurobehavioral Heterogeneity of Psychedelic Neurobiology in Humans Biological Psychiatry December 7, 2022
- Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders Neuropharmacology March 13, 2023
- Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs Neuropharmacology April 2, 2023
- Changes in synaptic markers after administration of ketamine or psychedelics: a systematic scoping review Frontiers in Psychiatry June 26, 2023